New immunotherapy targets for glioblastoma identified by mapping cell interactions

0
4

Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After receiving standard-of-care treatment (surgery followed by radiation and chemotherapy), fewer than half of patients will survive longer than 15 months. Only 5% of patients survive longer than five years.

Continue Reading this article here 

This site uses Akismet to reduce spam. Learn how your comment data is processed.